Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer

eClinicalMedicine(2023)

引用 1|浏览26
暂无评分
摘要
Bayer HealthCare.
更多
查看译文
关键词
Clinical outcomes,Radium-223,Metastatic castration-resistant prostate cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要